Principal Financial Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Principal Financial Group's ABUS Position: Q3 2026 in Review
Principal Financial Group increased its Arbutus Biopharma (ABUS) stake by 54% in Q3 2026, buying an estimated $31.8K and bringing the position to 18,896 shares worth $90.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2161.
Principal Financial Group first reported a position in ABUS in Q2 2022 and has held it in 17 quarters since. The position peaked at $118K in Q1 2023. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Principal Financial Group held 18,896 shares of Arbutus Biopharma worth $90.3K as of Q3 2026.
- Principal Financial Group bought 6,598 Arbutus Biopharma shares in Q3 2026, an estimated $31.8K.
- Arbutus Biopharma made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #2161 holding.
- Principal Financial Group first reported a position in Arbutus Biopharma in Q2 2022 and has held it in 17 quarters since.
- Principal Financial Group's Arbutus Biopharma position peaked at $118K in Q1 2023.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.